Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Olugbenga Olowokure
The long term goal is to improve survival of patients with unresectable pancreatic cancer. Additional potential benefits include increased probability of local control and decreased distant metastases.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically proven carcinoma of the pancreas that is locally advanced
ECOG performance status 0- 2
Adequate labs
No prior abdominal radiation therapy
No other concurrent clinically evident malignancy, except inactive nonmelanoma skin cancer, inactive cervical cancer, or other cancer for which the patient has been disease-free for 5 years
All disease must be encompassed within a radiotherapy portal
Not pregnant or nursing
You may not be if
Patient has metastatic disease on radiological staging
systemic therapy.
Patient has known active infection with HIV, hepatitis C or hepatitis B
Patient has serious medical risk factors involving any of the major organ systems such that the Investigator considers it unsafe for the patient to receive an experimental research drug.
Patient is deemed to be have obvious resectable disease at presentation
Received any investigational agent within a month prior to enrollment.
